Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Increased multiple sclerosis relapses related to lower prevalence of pain.
Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains.
The Nogo/ Nogo-66 receptor (NgR) signal is involved in neuroinflammation through the regulation of microglia inflammatory mediator expression.
Acrolein-mediated conduction loss is partially restored by potassium channel blockers.
Brain ageing and disorders of the central nervous system: kynurenines and drug metabolism.
Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
Subretinal angiostrongyliasis-induced optic neuritis.
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome.
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
Gray matter damage predicts the accumulation of disability 13 years later in MS.
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures.
Selectins and their ligands as potential immunotherapeutic targets in neurological diseases.
[Molecular targeted therapy for neuroimmunological diseases].
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells.
Synergistic Interactions between Cytokines and AVP at the Blood-CSF Barrier Result in Increased Chemokine Production and Augmented Influx of Leukocytes after Brain Injury.
CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation.
Implanting glass spinal cord windows in adult mice with experimental autoimmune encephalomyelitis.
A possible case of acute disseminated encephalomyelitis after Japanese encephalitis.
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
Cdon, a cell surface protein, mediates oligodendrocyte differentiation and myelination.
Biomarkers for MS: Unpuzzling the progressive multiple sclerosis puzzle.
Reliability of the Swedish version of the Exercise Self-Efficacy Scale (S-ESES): a test-retest study in adults with neurological disease.
Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
Cervical and ocular vestibular evoked myogenic potentials in multiple sclerosis participants.
Pages
« first
‹ previous
…
557
558
559
560
561
562
563
564
565
…
next ›
last »